Thurston Springer Miller Herd & Titak’s Virtus Biotech ETF BBP Stock Holding History

Thurston Springer Miller Herd & Titak’s Portfolio BBP Stock Details BBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-500	Closed	-$28.3K	–	1582
2024 Q1	$28.3K	Buy	+500	New	+$29.1K	0.01%	85

Other funds holding BBP

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

IFG

Independent Financial Group San Diego, California $5.35B AUM 43.78% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Thurston Springer Miller Herd & Titak's BBP Position: Q2 2024 in Review

Thurston Springer Miller Herd & Titak sold out of Virtus Biotech ETF (BBP) in Q2 2024, closing a stake of 500 shares — an estimated $28.3K sold.

Thurston Springer Miller Herd & Titak first reported a position in BBP in Q1 2024 and held it in 1 quarter. The position peaked at $28.3K in Q1 2024. 13 funds tracked by Wall St. Rank hold BBP as of Q2 2024.

Thurston Springer Miller Herd & Titak reported no remaining Virtus Biotech ETF position as of Q2 2024 after selling out during the quarter.
Thurston Springer Miller Herd & Titak sold 500 Virtus Biotech ETF shares in Q2 2024, an estimated $28.3K.
Thurston Springer Miller Herd & Titak first reported a position in Virtus Biotech ETF in Q1 2024 and held it in 1 quarter.
Thurston Springer Miller Herd & Titak's Virtus Biotech ETF position peaked at $28.3K in Q1 2024.
13 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q2 2024.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2024, filed 5 Jul 2024.